{"id":"W4390918445","doi":"10.1186/s13063-023-07834-8","title":"Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET","year":2024,"lang":"en","type":"article","venue":"Trials","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lanreotide; Tolerability; Octreotide; Internal medicine; Clinical trial; Dosing; Neuroendocrine tumors; Somatostatin; Gastroenterology; Adverse effect; Oncology; Surgery; Acromegaly","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008591675,0.0002884457,0.002992199,0.0002012313,0.00007460615,0.00004702124,0.0002555278,0.00004521415,0.00007339106],"category_scores_gemma":[0.0444984,0.0001280617,0.0004661905,0.0005017389,0.0005392821,0.0001244475,0.0001145715,0.0006836519,0.000001149044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006384443,"about_ca_system_score_gemma":0.0005103203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006876006,"about_ca_topic_score_gemma":0.00004137312,"domain_scores_codex":[0.9858535,0.00995041,0.002497809,0.0005660197,0.0007449497,0.0003873354],"domain_scores_gemma":[0.9582388,0.03987941,0.0009876023,0.000567621,0.0002049767,0.0001216274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9811625,0.001605115,0.002781748,0.000106758,0.0007169012,0.0002450039,0.0001268307,0.000013555,0.001057717,0.0001011974,0.00004411896,0.01203852],"study_design_scores_gemma":[0.9705687,0.01374887,0.01014555,0.0002867998,0.0009513387,0.00007202024,0.00009022704,0.00002513677,0.003478041,0.0004323734,0.00008859954,0.0001123052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976118,0.0005962904,0.00008655734,0.0007016843,0.0008486803,0.0214738,0.00004718863,0.00003313538,0.00009461535],"genre_scores_gemma":[0.9981691,0.0001598325,0.0006778117,0.00003515682,0.0003823146,0.0004012333,0.000009296935,0.00004113084,0.0001241138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03590672,"threshold_uncertainty_score":0.9635502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.130178862475752,"score_gpt":0.4812644040670503,"score_spread":0.3510855415912983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}